Back

Multimodal screening of transthyretin amyloid cardiomyopathy through artificial intelligence applied to electrocardiographic images and point-of-care ultrasound: a multi-center study

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease (2) Clinical HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Evangelos K Oikonomou

Yale School of Medicine, New Haven (United States of America)

8 More presentations in this session

Presentation thumbnail
Effects of tafamidis on pacemaker therapy
Doctor M. Figueiredo (Barreiro, PT)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics, mortality outcomes and survival predictors of transthyretin cardiac amyloidosis in an Asian registry
Doctor V. Putri (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
A descriptive journey through the heart of transthyretin cardiac amyloidosis
Doctor M. Rodrigues Simoes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Diagnostic value of the right ventricular wall thickness and free wall strain ratio in distinguishing hypertrophic cardiomyopathy and wild-type transthyretin cardiac amyloidosis
Doctor E. Mata (Creixomil, PT)
Abstract Slides Video
Presentation thumbnail
Red-flags for cardiac amyloidosis in real life of an internal medicine department
Doctor I. Fiteni Mera (Zaragoza, ES)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in myocardial disease (2)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Characterizing the progression of subclinical cardiac amyloidosis through artificial intelligence applied to electrocardiographic images and echocardiograms
thumbnail
Congress Presentation
Interpretable artificial intelligence-based transthyretin amyloid cardiomyopathy detection in patients with severe aortic stenosis
thumbnail
Congress Presentation
CA-AI Echo – Diagnosis of cardiac amyloidosis on echocardiography using artificial intelligence: a multicentre international development and validation study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources